Innovus Pharmaceuticals Inc Aktie OTC Bulletin Board
Aktien
US45778V1061
Pharmazeutika
Schlusskurs
Andere Börsenplätze
|
||
- USD | - |
|
Manager | Titel | Alter | Seit |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | - |
Chief Operating Officer | - | 01.06.18 | |
Steven Klayman
PRN | Corporate Officer/Principal | - | - |
% 1. Jan. | Kap. | |
---|---|---|
+56.20% | 816 Mrd. | |
+39.64% | 634 Mrd. | |
-7.50% | 351 Mrd. | |
+15.92% | 323 Mrd. | |
+6.94% | 293 Mrd. | |
+13.40% | 238 Mrd. | |
+0.82% | 222 Mrd. | |
+13.34% | 218 Mrd. | |
+8.07% | 167 Mrd. |